Families facing HSCT often ask why cost estimates vary so widely. The answer is that transplant is a process, not an event. Costs are influenced by:
  • Length of hospitalisation
  • Infections or complications
  • ICU admissions
  • GVHD treatment
  • Medications and immune support
  • Duration of isolation
  • Speed of immune recovery
Two children undergoing the same procedure at the same centre can have vastly different courses. In DOCK8 patients, pre-existing viral disease, including severe molluscum can increase complexity, prolong recovery, and add cost. This is why experienced centres plan for contingencies and why fundraising targets include buffers for unforeseen needs. This is not about expecting the worst, but about planning carefully because preparation gives children the best possible chance.
  • EBMT/ESID IEI HSCT guidelines (complications and variables affecting course). EBMT+1

  • Conditioning regimens review in PID (why intensity/approach varies; effects on outcomes). PMC

  • NHS England commissioning policy for allo-HSCT in primary immunodeficiencies (HSCT is high-cost, specialised; risks/morbidity). NHS England